2023-11-11T04:19:45+03:00[Europe/Moscow] en true <p>NSAIDS, lithium, interferons, Denosumab(RANKL inhibitors)</p>, <p>children</p>, <p>onset edema &amp; weight gain</p>, <p>Hematuria, RBC casts, elevated SCr, HTN</p>, <p>Proteinuria, hypoalbuminemia, hypercoaguable state, hyperlipidemia</p>, <p>&gt; 3.5 g/day</p>, <p>&lt; 3 g/day </p>, <p>foot process effacement; podocytes</p>, <p>prednisone</p>, <p>c</p>, <p>prolonged bed rest, high dose steroids, post-surgery </p>, <p>hydralazine </p>, <p>butterfly rash/red patches, joint pain</p>, <p>b</p>, <p>b</p>, <p>e</p>, <p>baseline eye exam within 6 months of starting then every year</p>, <p>Imuran </p>, <p>corticosteroids, RAAS blockade, diuretics</p>, <p>sodium restriction</p>, <p>less albumin; loops bind to albumin causing less drug to reach nephron; intestinal edema decreases GI absorption of loops</p>, <p>combine diuretics with different MOA</p>, <p>negative proteinuria </p>, <p>clinical feature + blood/urine tests + kidney biopsy </p>, <p>anti-ds antibodies, anti-smith antigen </p>, <p>immunosuppression; mycophenolate or azathioprine </p> flashcards
Renal Diseases

Renal Diseases

  • NSAIDS, lithium, interferons, Denosumab(RANKL inhibitors)

    Which drugs can cause Minimal Change disease? (4)

  • children

    Minimal Change disease is most common in _________.

  • onset edema & weight gain

    How does Minimal change disease usually present itself?

  • Hematuria, RBC casts, elevated SCr, HTN

    What are signs and symptoms of Nephritic syndrome? (4)

  • Proteinuria, hypoalbuminemia, hypercoaguable state, hyperlipidemia

    What are signs and symptoms of Nephrotic syndrome? (4)

  • > 3.5 g/day

    Proteinuria in Nephrotic Syndrome =

  • < 3 g/day

    Proteinuria in Nephritic Syndrome =

  • foot process effacement; podocytes

    In minimal change disease, ___________ is a notable sign on a microscope when examining the ________.

  • prednisone

    What is the 1st line therapy for Minimal Change Disease?

  • c

    Which can increase liver enzymes?

    a) cyclophosphamide

    b) mycophenolate mofetil

    c) cyclosporine

    d) corticosteroids

    e) tacrolimus

    f) rituximab

  • prolonged bed rest, high dose steroids, post-surgery

    Which patients with minimal change disease are at risk of hypercoagulability? (3)

  • hydralazine

    Which anti-hypertensive can cause Lupus Nephritis?

  • butterfly rash/red patches, joint pain

    What are the classic signs of Lupus?(2)

  • b

    Which can cause leukopenia?

    a) tacrolimus

    b) azathioprine

    c) mycophenolate mofetil

    d) cyclophosphamide

    e) hydroxychloroquine

  • b

    Which can cause cancer?

    a) tacrolimus

    b) azathioprine

    c) mycophenolate mofetil

    d) cyclophosphamide

    e) hydroxychloroquine

  • e

    Which can cause retinopathy?

    a) tacrolimus

    b) azathioprine

    c) mycophenolate mofetil

    d) cyclophosphamide

    e) hydroxychloroquine

  • baseline eye exam within 6 months of starting then every year

    What are the clinical guidelines for Hydroxychloroquine?

  • Imuran

    Azathioprine Brand Name?

  • corticosteroids, RAAS blockade, diuretics

    What are the treatment options for Minimal Change Disease? (3)

  • sodium restriction

    What is the nonpharmacological recommendation for patients with Minimal

    Change Disease?

  • less albumin; loops bind to albumin causing less drug to reach nephron; intestinal edema decreases GI absorption of loops

    Why does Diuretic-Resistance occur in Nephrotic Syndrome? (2)

  • combine diuretics with different MOA

    How can we overcome diuretic-resistance in Nephrotic syndrome?

  • negative proteinuria

    What is the confirmation of therapy success in Minimal Change Disease?

  • clinical feature + blood/urine tests + kidney biopsy

    How is Lupus Nephritis diagnosed? (3

  • anti-ds antibodies, anti-smith antigen

    Which serology findings are most specific to Lupus Nephritis? (2)

  • immunosuppression; mycophenolate or azathioprine

    How do we treat Lupus Nephritis? (2)